03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Methergin Ampoules* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Novartis |
Responsible Party | Novartis Pharma AG |
Origin | Switzerland |
Manufacturer | Novartis Pharma AG |
Origin | Switzerland |
ATC | G02AB01 |
Methergin Ampoules* :
Methergin Ampoules* :
Methergin Ampoules* :
Methergin Ampoules* :
Methergin Ampoules* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Methergin Ampoules* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Anaphylactic reactions | Very rare |
Angina pectoris | Not known |
Arterial spasm | Rare |
Arteriospasm coronary | Very rare |
Atrioventricular block (AVB) | Not known |
Bradycardia | Rare |
Cerebrovascular accident | Not known |
Chest pain | Uncommon |
Convulsion | Uncommon |
Diarrhoea (Diarrhea) | Very rare |
Hallucination | Very rare |
Headache | Common |
Hyperhidrosis | Uncommon |
Hypertension | Common |
Hypotension | Uncommon |
Lightheadedness | Uncommon |
Muscle spasms | Very rare |
Myocardial infarction | Very rare |
Nasal congestion | Very rare |
Nausea | Uncommon |
Palpitations | Rare |
Paraesthesia (paresthesia) | Not known |
Skin Eruption | Common |
Tachycardia | Rare |
Thrombophlebitis | Very rare |
Tinnitus | Very rare |
Vasoconstriction | Rare |
Vasospasm | Rare |
Ventricular fibrillation | Not known |
Ventricular tachycardia | Not known |
Vomiting | Uncommon |
Methergin Ampoules* :
Methergin Ampoules* :
NB : Products With Same Indication |
Different Units By MoH Code
Methergin Ampoules* MoH 836 :
Form | Solution for injection |
Packaging | Ampoules |
Package Size | 100x1ml |
Strength | 0.2mg/ml |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 1711/72 |
Submission date | 01/01/1972 |
Registration Year | 1972 |
Archived Date | 2014 |
Price Comparison
● Country: | KSA | |
● Package Size: | 5ml | |
● Public Price: | 10.15 SAR | ( 239,946.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 10,15 SAR | ( 236,400.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 5x1ml | |
● Public Price: | 7.55 CHF | ( 780,821.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 1,51 CHF | ( 103,420.00 LBP ) |
● Exfactory Price: | 3.03 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 5 | |
● Public Price: | 6.47 EUR | ( 626,787.72 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 1,294 EUR | ( 96,876.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 100x1ml | |
● Public Price: | 18.12 OMR | ( 4,180,900.08 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,1812 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 100x1ml | |
● Public Price: | 69.57 EUR | ( 6,739,663.32 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,6957 EUR | ( 0.00 LBP ) |
● Pharmacy Price: | 62.57 EUR | ( 6061531.32 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 5x1ml | |
● Public Price: | 4.48 EUR | ( 434,004.48 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 0,896 EUR | ( 0.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 29/04/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Kuweit | |
● Package Size: | 100 | |
● Public Price: | 14.11 KWD | ( 4,142,427.91 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,1411 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 11.92 KWD | ( 3499485.52 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File